---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-004095"
form_type: "8-K"
ticker: "BRGX"
cik: "0001593184"
company_name: "BIOREGENX, INC."
filed_at: "2024-06-11T23:59:59+00:00"
generated_at: "2026-06-01T05:03:14.370227+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioRegenx restates Q1 2024 financials; appoints Weinberg & Co. as new auditor

## Summary
- Engaged Weinberg & Company as new independent accountant for fiscal years ended Dec 31, 2023 and 2022, effective June 10, 2024.
- Concluded Q1 2024 Form 10-Q and 10-Q/A should no longer be relied upon due to lack of auditor review prior to filing.
- Management evaluating restatement impact on financials and internal controls; will file amended 10-Q/A as soon as practical.
- No prior consultations with Weinberg on accounting principles or disagreements during past two fiscal years and subsequent interim period.

## SEC filing metadata
- accession: 0001683168-24-004095
- form_type: 8-K
- ticker: BRGX
- cik: 0001593184
- company_name: BIOREGENX, INC.
- filed_at: 2024-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 4.01, 4.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1593184/000168316824004095/0001683168-24-004095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1593184/000168316824004095/bioregenx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-004095
- JSON: https://secwatch.observer/filing/0001683168-24-004095.json
- Plain text: https://secwatch.observer/filing/0001683168-24-004095.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.